We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
(Reuters) -Gilead Sciences said on Thursday it would donate about 5,000 vials of its antiviral drug remdesivir to the Rwanda ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $84.95 which represents a slight increase of $0.28 or 0.33% from the prior close of $84.67. The stock opened at $84 ...
GlobalData on MSN13d
Gilead signs agreements to facilitate access to HIV prevention drugGilead Sciences has announced the signing of voluntary licencing agreements with six generic pharmaceutical manufacturers to ...
Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of new findings from its antiviral research ...
6d
Future Financial Wealth Managment LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in ...
The U.S.-based drugmaker also plans to provide the companies branded version of the drug, lenacapavir, in 18 countries, such ...
CNW/ -- (NASDAQ:CTSH) today announced significant enhancements to its Neuro® AI platform, aimed at enabling enterprises to ...
Gilead Sciences Inc. has announced a new licensing deal to provide its twice-yearly experimental HIV prevention drug, lenacapavir, to six ...
Oct 3 (Reuters) - Gilead Sciences (GILD.O), opens new tab said ... before spreading through contact with the bodily fluids of those infected. Sign up here. Reporting by Mariam Sunny in Bengaluru ...
Gilead Sciences said on Thursday it would donate ... before spreading through contact with the bodily fluids of those infected. REUTERS Join ST's Telegram channel and get the latest breaking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback